| P2093 | author name string | A M Ballesta | |
| | A Soler | |
| | J M Martínez | |
| | A Borrell | |
| | E Casals | |
| | A Fortuny | |
| | C Aibar | |
| | J Ojuel | |
| P2860 | cites work | Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group. | Q38507170 |
| | Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy. | Q40400831 |
| | In vitro effects of pregnancy-associated plasma protein-A: artifacts due to heparin | Q41947209 |
| | First-trimester maternal serum human chorionic gonadotrophin as a marker for fetal chromosomal disorders. The Dutch Working Party on Prenatal Diagnosis | Q67547042 |
| | Seminal plasma levels of PAPP-A in normospermic and oligospermic men and tissue localization of PAPP-A in the male genital tract | Q68946881 |
| | Serum PAPP-A measurements in first-trimester screening for Down syndrome | Q71610146 |
| | First-trimester biochemical screening for Down syndrome with the use of PAPP-A, AFP, and beta-hCG | Q71620967 |
| | Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A, markers for fetal Down syndrome at 8-14 weeks | Q71639239 |
| | Serum PAPP-A and free beta-hCG are first-trimester screening markers for Down syndrome | Q71677716 |
| | First‐trimester free beta (hCG) screening for Down syndrome | Q72099388 |
| | Immunohistochemical localization of pregnancy-associated plasma protein a in decidua and trophoblast: Comparison with human chorionic gonadotrophin and fibrin | Q72751629 |
| | Screening of maternal serum for fetal Down's syndrome in the first trimester | Q74378735 |
| P433 | issue | 1 | |
| P921 | main subject | Down syndrome | Q47715 |
| P304 | page(s) | 8-11 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Prenatal Diagnosis | Q15760059 |
| P1476 | title | First-trimester biochemical markers for Down syndrome | |
| P478 | volume | 19 | |